Home › Funds › HighVista Strategies LLC › PHVS

HighVista Strategies LLC position in PHVS

PHARVARIS N V · Health Care

HighVista Strategies LLC reported holding 126,174 shares of PHVS (PHARVARIS N V) in its Q3 2026 13F filing — a position valued at US$4.0M, representing 1.05% of its reported portfolio and ranking #27 among its reported holdings. HighVista Strategies LLC has disclosed PHVS holdings in 10 of the last 11 reported quarters, going back to Q1 2024.

Latest position (Q3 2026)126.17K sh
Reported value held$4.00M
Portfolio Weight1.05%
First reportedQ1 2024
Last changeReduce
Updated2026-11-13

Last updated: 2026-11-13 · Source: SEC EDGAR Form 13F-HR

How HighVista Strategies LLC's PHVS position evolved

HighVista Strategies LLC first disclosed a stake in PHVS in Q1 2024 at 16,750 shares (US$387K). The position peaked in Q2 2026 at 160,494 shares, worth US$5.5M. Across 10 filings, HighVista Strategies LLC increased the stake 3 time(s), trimmed it 2 time(s) and left it unchanged 3 time(s). The most recent filing (Q3 2026) shows 126,174 shares valued at US$4.0M — a reduction of -34,320 shares quarter over quarter.. Notable position changes include a 36% increase in Q3 2024, a 40% trim in Q1 2026 (shares rose 22% over the following quarter), a 64% increase in Q2 2026 (shares fell 8% over the following quarter).

Quarter by quarter

QuarterSharesValueChange
Q1 2024 16.75K $387.09K New
Q2 2024 16.75K $314.90K Hold
Q3 2024 22.77K $421.66K Add
Q4 2024 22.77K $436.46K Hold
Q1 2025 22.77K $357.46K Hold
Q2 2025 23.74K $417.81K Add
Q4 2025 162.37K $4.51M New
Q1 2026 97.87K $2.76M Reduce
Q2 2026 160.49K $5.55M Add
Q3 2026 126.17K $4.00M Reduce

Dots on the line are colored by change type; missing quarters mean no position was reported.

About PHVS and 13F data

PHVS (PHARVARIS N V) is a Health Care company. 50 other funds we track also report a position in PHVS — the largest reported positions include GENERAL ATLANTIC, L.P. (US$226.5M), Foresite Capital Management IV, LLC (US$165.2M), venBio Partners LLC (US$160.6M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding PHVS

All PHVS fund holders →

FAQ

How long has HighVista Strategies LLC held PHVS?

HighVista Strategies LLC has disclosed PHVS holdings in 10 of the last 11 reported quarters, going back to Q1 2024.

What is HighVista Strategies LLC's current position in PHVS?

As of Q3 2026, HighVista Strategies LLC holds 126.17K shares of PHVS (PHARVARIS N V), valued at $4.00M, representing 1.05% of its reported portfolio and ranking #27.

Has HighVista Strategies LLC been buying or selling PHVS?

In the latest 13F filing (Q3 2026), HighVista Strategies LLC reduced its position in PHVS. The position peaked in Q2 2026 at 160.49K shares.

Which other funds hold PHVS?

Other major institutional holders of PHVS include GENERAL ATLANTIC, L.P., Foresite Capital Management IV, LLC, venBio Partners LLC, among 50 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.